Mdc Pharmaceuticals Limited
Mdc Pharmaceuticals Limited is a Public Non-govt company company incorporated in 1994 and based in Chandigarh, India. Mdc Pharmaceuticals Limited operates in Chemical substances used in the manufacture of anti-biotic, manufacturing (NIC 24231) with authorized capital of ₹20.00 Cr and paid-up capital of ₹12.24 Cr. For 2021-22, the company reported revenue of ₹45.91 Cr and profit after tax of ₹0. The board has 3 active directors. RegisterKaro's provisional Compliance Health Score for the company is 100/100 (grade A), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
MDC PHARMACEUTICALS LIMITED is the legal entity of MDC Pharmaceuticals and MDC Pharmaceutical.
Quick facts
Directors
3 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +33d | filed |
| MGT-7 | FY2024-25 | 24 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 21 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +39d | filed |
| MGT-7 | FY2022-23 | 27 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Mdc Pharmaceuticals Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 580253465 | Kotak Mahindra Bank Ltd(Bank) | ₹7.39 Cr | 19 Sep 2022 | Satisfied |
| 563465662 | HDFC Bank Ltd(Bank) | ₹22.30 Cr | 19 Sep 2021 | Open |
| 925038132 | ICICI Bank Ltd(Bank) | ₹20.04 Cr | 19 Sep 2020 | Open |
| 204198895 | Axis Bank Ltd(Bank) | ₹11.12 Cr | 19 Sep 2020 | Satisfied |
| 537249738 | HDFC Bank Ltd(Bank) | ₹14.29 Cr | 12 Mar 2021 | Open |
Charge IDs, lenders & amounts for Mdc Pharmaceuticals Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2021-22 | — | ||||
| 2020-21 | — |
Detailed Financials
2 FYs| Line item | 2021-22 | 2020-21 |
|---|---|---|
| Income statement | ||
| Revenue from operations | ||
| Other income | ||
| Total income | ||
| Total expenses | ||
| Profit before tax | ||
| Profit / (Loss) after tax | ||
| Balance sheet | ||
| Equity / Net worth | ||
| Borrowings | ||
| Current liabilities | ||
| Total liabilities | ||
| Current assets | ||
| Cash & equivalents | ||
| Total assets | ||
| Employees | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2021-22 | -7.0% | — | — | |
| Profit after Tax2021-22 | — | — | — | |
| Net Worth2021-22 | -1.0% | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2020-21 | +0.00% | — | +0.00% | +0.00% | — | |||
| 2021-22 | +0.00% | -5.91% | +0.00% | +0.00% | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 3,34,17,700 | 78.26% |
| Institutional Investors | 1 | 19,25,696 | 4.51% |
| Public & Others | 7 | 73,57,783 | 17.23% |
Promoter, institutional & public holding for Mdc Pharmaceuticals Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
228 peersTop 10 in Chemical substances used in the manufacture of anti-biotic, manufacturing
by healthView all ›Events & timeline
4External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.